Preferred Label : Autologous Lymphoma Cell/Allogeneic Dendritic Cell Electrofusion Hybrid Vaccine;
NCIt definition : A cell-based cancer vaccine consisting of hybrid cells created by electrofusing allogeneic
dendritic cells (DCs) and autologous lymphoma cells with potential immunostimulating
and antitumor activities. Upon administration, autologous lymphoma cell/allogeneic
dendritic cell electrofusion hybrid vaccine may stimulate the immune system to mount
a specific cytotoxic T-lymphocyte (CTL) response against specific autologous lymphoma-associated
antigens, resulting in lymphoma cell apoptosis.;
NCI Metathesaurus CUI : CL412320;
Origin ID : C85451;
UMLS CUI : C2827674;
Semantic type(s)
- concept_is_in_subset
